Last reviewed · How we verify

NCT03900832: EPR

Effects of Heating on Exercise Pressor Reflex in Peripheral Artery Disease: Exercise Ability

Completed EARLY_PHASE1 Last updated 16 September 2025
What this trial tests

EARLY_PHASE1 trial testing Without Heating in PAD in 33 participants. Completed in 31 July 2025.

Timeline
15 May 2019
Primary endpoint
31 July 2025
31 July 2025

Quick facts

Lead sponsorMilton S. Hershey Medical Center
PhaseEARLY_PHASE1
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designcrossover
Maskingsingle
Primary purposebasic science
Enrollment33
Start date15 May 2019
Primary completion31 July 2025
Estimated completion31 July 2025
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Milton S. Hershey Medical Center

Who can join

Adults 21 to 85, any sex, with PAD. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The study objectives of this projects are to examine the hypothesis that the sympathetic and blood pressure responses to exercise will be attenuated during and after heat exposure in patients with peripheral artery disease, via altering the sensitivity of the muscle afferent receptors.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for PAD

Currently open trials in the same condition.

Other Milton S. Hershey Medical Center trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03900832.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing